ym 09151-2 has been researched along with butaclamol in 1 studies
Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (butaclamol) | Trials (butaclamol) | Recent Studies (post-2010) (butaclamol) |
---|---|---|---|---|---|
249 | 6 | 13 | 233 | 3 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strange, PG; Vile, JM | 1 |
1 other study(ies) available for ym 09151-2 and butaclamol
Article | Year |
---|---|
Comparison of [3H]nemonapride and [3H]spiperone binding to D2(long) dopamine receptors.
Topics: Animals; Benzamides; Binding, Competitive; Butaclamol; CHO Cells; Cricetinae; Dopamine Antagonists; Kinetics; Radioligand Assay; Rats; Receptors, Dopamine D2; Recombinant Proteins; Spiperone; Transfection; Tritium | 1995 |